Evaluate RGNX stock safety — financial health, volatility, institutional backing, and risk factors.

What are the risks of investing in RGNX? | Glauxie AI

Q: What are the risks of investing in RGNX?

REGENXBIO Inc. (RGNX) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Curran Simpson. REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce... Employees: 200,000.

Q: How much debt does RGNX have?

Review RGNX total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Q: Is RGNX a good long-term investment?

Evaluate RGNX as a long-term investment using fundamental scores, growth metrics, and risk assessment.

What are the risks of investing in RGNX?

🦉

REGENXBIO Inc. (RGNX)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOCurran Simpson

REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates...

Key Executives

Name	Title
Craig Malzahn	Executive Vice President of Product Development & Chief Technology Officer
Curran Simpson	President, Chief Executive Officer & Director
Jahannaz Dastgir	Clinical Development Lead
Mitchell Chan	Executive Vice President & Chief Financial Officer
Nina Hunter	SVP of Global Regulatory Strategy and Quality
Olivier Danos	Executive Vice President & Chief Scientific Officer

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

RGNX Profile Financials

Is RGNX stock safe? How much debt does RGNX have? Is RGNX a good long-term investment?